PAX3-FOXO1 and FGFR4 in alveolar rhabdomyosarcoma. (Q39481211)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21882254%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

PAX3-FOXO1 and FGFR4 in alveolar rhabdomyosarcoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21882254%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21882254%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Martijn A van der Ent

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21882254%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Gerard C Grosveld

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21882254%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

31 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21882254%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

published in

Molecular Carcinogenesis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21882254%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21882254%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21882254%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

807-815

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21882254%20AND%20SRC:MED&resulttype=core&format=json

PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group

12 February 2020

cites work

1 reference

Nonrandom chromosome alterations in rhabdomyosarcoma

21 January 2018

1 reference

Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma

21 January 2018

1 reference

Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1.

21 January 2018

1 reference

Pax3-fkhr and pax7-fkhr fusion genes impact outcome of alveolar rhabdomyosarcoma in children.

21 January 2018

1 reference

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

21 January 2018

1 reference

Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas

21 January 2018

1 reference

Genome-Wide Identification of PAX3-FKHR Binding Sites in Rhabdomyosarcoma Reveals Candidate Target Genes Important for Development and Cancer

21 January 2018

1 reference

Pax3 regulation of FGF signaling affects the progression of embryonic progenitor cells into the myogenic program

21 January 2018

1 reference

Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway

21 January 2018

1 reference

Role of the INK4a locus in tumor suppression and cell mortality.

21 January 2018

1 reference

Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy

21 January 2018

1 reference

FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts

21 January 2018

1 reference

Independent repression of bile acid synthesis and activation of c-Jun N-terminal kinase (JNK) by activated hepatocyte fibroblast growth factor receptor 4 (FGFR4) and bile acids

21 January 2018

1 reference

Production of high-titer helper-free retroviruses by transient transfection

21 January 2018

1 reference

Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas

21 January 2018

1 reference

The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain.

21 January 2018

1 reference

The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc

21 January 2018

1 reference

A cancer cell metalloprotease triad regulates the basement membrane transmigration program

21 January 2018

1 reference

IRIZIO : a novel gene cooperating with PAX3-FOXO1 in alveolar rhabdomyosarcoma (ARMS)

21 January 2018

1 reference

The PAX3-FKHR fusion gene of rhabdomyosarcoma cooperates with loss of p16INK4A to promote bypass of cellular senescence

21 January 2018

1 reference

High expression of the PAX3-FKHR oncoprotein is required to promote tumorigenesis of human myoblasts

21 January 2018

1 reference

Defining the cooperative genetic changes that temporally drive alveolar rhabdomyosarcoma

21 January 2018

1 reference

The pediatric preclinical testing program: description of models and early testing results.

21 January 2018

1 reference

Distinct transcriptional control and action of fibroblast growth factor receptor 4 in differentiating skeletal muscle cells

21 January 2018

1 reference

Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention

21 January 2018

1 reference

Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness

21 January 2018

1 reference

Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation

21 January 2018

1 reference

Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.

21 January 2018

1 reference

Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma

21 January 2018

1 reference

Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group

21 January 2018

1 reference

Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development

21 January 2018

1 reference

P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines

21 January 2018

1 reference

The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells

21 January 2018

1 reference

Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression

21 January 2018

1 reference

FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects

21 January 2018

1 reference

Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma

21 January 2018

1 reference

Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer

21 January 2018

1 reference

Amplification of fgfr4 gene in human breast and gynecological cancers

21 January 2018

1 reference

Resistance to chemotherapy is associated with fibroblast growth factor receptor 4 up-regulation

21 January 2018

1 reference

Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group

21 January 2018

1 reference

Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.

21 January 2018

1 reference

Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma

21 January 2018

1 reference

CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion.

21 January 2018

1 reference

Mutation and expression analyses of the MET and CDKN2A genes in rhabdomyosarcoma with emphasis on MET overexpression

21 January 2018

1 reference

ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status.

21 January 2018

1 reference

Functional FGFR4 Gly388Arg Polymorphism Predicts Prognosis in Lung Adenocarcinoma Patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MC.20848

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21882254%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21882254%20AND%20SRC:MED&resulttype=core&format=json